SecBot SecBot
425 ·Filed Oct 21, 2026

DMAA

Drugs Made In America Acquisition Corp.
MIXED
Impact 6/10
Horizonweeks Processed5d 19h ago SEC0001213900-26-111424
Rule 425 M&A communications
Actionable Insight ◆ Mixed

The key binary catalyst is the November 1, 2026 deadline for the APQC Acquisition. If it closes by then, the deal proceeds at the higher $2.85 billion valuation; if not, the valuation automatically drops to $1.71 billion. Watch for any press release or 8-K before Nov 1 confirming or denying the APQC Acquisition's completion, and for the fairness opinion from Joel A. Gallo expected by Oct 26.

DirectionMixed
Confidencemedium
Horizonweeks
Latest settled — T+1d ⚠ clustered
DMAA ▼ -0.05% at T+1d
NEUTRAL call -0.05% · α vs SPY +0.48% · entry $10.88 → $10.88
Next anchor: T+5d in 19h
Entry = T+0 close
Oct 21, 2026
via day close
T+1d
-0.05%
call -0.05% · α +0.48%
$10.88
settled 5d ago
T+5d
Pending
in 19h
T+20d
Pending
in 22d
T+60d
Pending
in 3mo

Price Chart

Loading chart...

Executive Summary

DMAA and PAGC amended their merger agreement to provide for a standalone closing valuation of $1.71 billion if PAGC's acquisition of APQC Inc and UltraSolar IP (the APQC Acquisition) is not completed by November 1, 2026. The prior fairness opinion firm was replaced by sole practitioner Joel A. Gallo after it determined a dual opinion was needed. The deal can still close at the original $2.85 billion valuation if the APQC Acquisition is completed by the deadline, with a hard cap of $2.85 billion on total consideration.

Key Financial Metrics

Deal Value
$1.7B
Deal Type
merger

Key Facts

  • Amendment No. 1 to the Merger Agreement provides for an automatic reduction of the Closing Valuation from $2.85 billion to $1.71 billion (Standalone Closing Valuation) upon a Reversion Event — the earliest of: APQC Acquisition not completed by Nov 1, 2026; termination of the APQC Acquisition agreement; or written determination by DMAA's independent directors that the APQC Acquisition cannot be completed.
  • The prior fairness opinion firm was terminated effective Oct 2, 2026, after determining the IP valuation required a dual opinion. Independent director Joel A. Gallo was engaged on Oct 12, 2026, to render the fairness opinion on the $1.71 billion standalone valuation, expected by Oct 26, 2026 (subject to information delivery).
  • If a Reversion Event occurs, the condition to closing requiring the APQC Acquisition is deleted, and DMAA's right to terminate if the APQC Acquisition is not completed by Dec 31, 2026, is also deleted.
  • After a Reversion Event, the parties may later increase the Closing Valuation by adding the APQC Acquisition or other assets at independently appraised value, up to the $2.85 billion Ceiling, via a further amendment supported by a supplemental fairness opinion.
  • The Merger Consideration will be paid in full in DMAA shares at the Reference Price, with no earnout or contingent consideration.
  • If the APQC Acquisition is completed by Nov 1, 2026, and no Reversion Event occurs, the original $2.85 billion valuation terms continue.

Financial Impact

Potential reduction in deal valuation from $2.85 billion to $1.71 billion (a $1.14 billion or 40% decrease) if the APQC Acquisition fails by Nov 1, 2026. The $1.71 billion standalone valuation is the new baseline if a Reversion Event occurs.

dealValuevaluation

Risk Factors

  • APQC Acquisition may not close by Nov 1, triggering a 40% reduction in deal valuation.
  • Fairness opinion from sole practitioner Joel A. Gallo may not be delivered on time or may not conclude the deal is fair, which is a condition to closing.
  • Shareholder redemptions could reduce cash available at closing, creating a Minimum Cash Condition risk.
  • The standalone $1.71 billion valuation may face shareholder opposition or regulatory scrutiny as a de-SPAC transaction.

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
425 Filing (Primary)0001213900-26-111424
Document: ea030886001ex2-1.htm0001213900-26-111424
Document: 0001213900-26-111424-index-headers.html0001213900-26-111424
Document: 0001213900-26-111424-index.html0001213900-26-111424
Document: 0001213900-26-111424.txt0001213900-26-111424
5 reports for DMAA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for DMAA — sortable, filterable
TypeNow
Oct 21, 2026
5d ago
425
MIXED ★ 6/10
$10.88awaiting T+60—$10.88 (+0.00%)
Oct 21, 2026
5d ago
8-K
MIXED ★ 6/10
$10.88awaiting T+60—$10.88 (+0.00%)
Sep 14, 2026
6w ago
425
NEUTRAL ★ 5/10
$10.84awaiting T+60—$10.88 (+0.37%)
Jul 20, 2026
14w ago
425
MIXED ★ 6/10
$10.70 $10.86▲ +1.50%▼ −2.48%$10.88 (+1.68%)
Jul 20, 2026
14w ago
8-K
BULLISH ★ 5/10
$10.70 $10.86▲ +1.50%▼ −2.48%$10.88 (+1.68%)
Showing 5 of 5

US Market Status

Market Open — Closes in 2h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 21, 2026